Dale Charlton PhD

Dr. Dale Charlton, ATS Sortimat. Dale has spent a life long career in life sciences and biotechnology covering work in both the academic and industrial sectors. Following his first degree in biological sciences and spells at Porton Down and Pittman Moore vaccines (Formerly Glaxo Animal Health) developing vaccines/adjuvant systems, he settled back into the biotech industry developing therapeutic Monoclonal Antibodies at Celltech.

Dale successfully undertook a PhD at Pfizer Drug Discovery and the University of Nottingham on peptide drug candidates before moving out of academia and into the supply industry in the field of robotics and automation for the biopharmaceutical industry. He progressed from Product Specialist to Managing Director of an independent life science company until moving to his role as Director of Business Development for the Optima Group Pharma, Germany and more recently to ATS Sortimat.